Navigation Links
Advanced Life Sciences Announces Third Quarter 2008 Financial Results
Date:11/6/2008

ngs with the Securities and Exchange Commission.

ADVANCED LIFE SCIENCES HOLDINGS, INC. AND SUBSIDIARY

(A Development Stage Company)

September 30, December 31,

CONSOLIDATED BALANCE SHEETS 2008 2007

(Unaudited)

ASSETS

CURRENT ASSETS:

Cash and cash equivalents $7,766,597 $18,324,991

Grant receivable 32,006 -

Prepaid insurance 329,363 251,493

Prepaid clinical trial expenses - 926,168

Other prepaid expenses and deposits 211,874 140,359

Total current assets 8,339,840 19,643,011

PROPERTY AND EQUIPMENT:

Furniture and fixtures 237,907 221,417

Laboratory equipment 159,186 159,186

Computer software and equipment 253,851 242,707

Leasehold improvements 502,798 177,253

Total property and equipment - at cost 1,153,742 800,563

Less accumulated depreciation (717,249) (542,032)

Property and equipment - net 436,493 258,531

OTHER ASSETS:

Deferred financing costs 361,250 -

Other long-term assets 10,000 10,000

Total other assets 371,250 10,000

TOTAL ASSETS $9,147,583 $19,911,542

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES:

Accounts payable $273,140 $2,685,751

Accrued milestone payable 10,000,000 -

Accrue
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... to $5.8 million and provides a good start to Q4.  The ... America and one in the Middle East ... record levels," said Peter Bruijns , President & CEO. "Total ... Q3 than they have been for any complete year since the ...
(Date:10/20/2014)... PLAINSBORO, N.J. (PRWEB) October 20, 2014 ... that the Sidney Kimmel Cancer Center at Thomas ... program. , Through the Strategic Alliance Partnership ... and OncLive will collaborate to raise awareness of ... cancer treatment, and other projects. Clinicians and other ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The 9th Annual ... take place at the Congress Center Basel, ... now available at http://www.abim.ch . ... from all over the globe will exchange ... products and developments on the world market. ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3
... PRXL ), a leading global biopharmaceutical services,organization, ... Goldberg, M.D.,to Chief Operating Officer (COO). Dr. Goldberg ... Perceptive Informatics at,PAREXEL. He will continue to oversee ... von Rickenbach, Chairman and Chief Executive Officer of ...
... Sagent Pharmaceuticals, Inc.,a privately-held specialty pharmaceutical company, today ... USP, and cefuroxime for,injection, USP, two broad spectrum ... Sagent,s ceftriaxone for,injection will be available to the ... single,dose vials, as well as 1g and 2g ...
... PALO ALTO, Calif., July 16 Jazz,Pharmaceuticals, Inc. ... has entered,into definitive agreements with selected investors to ... of (i) one share of the Company,s,common stock, ... (ii) a,warrant to purchase 0.45 of a share ...
Cached Biology Technology:PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 2PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 3PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer 4Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP 2Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP 3Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering 2Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering 3
(Date:10/15/2014)... As our ability to assess the pandemic risk from ... developments, we must not allow ourselves to become complacent ... an international consortium of scientists. , Influenza pandemics arise ... have yet to develop widespread immunity – spreads in ... in the past 100 years, the worst of which ...
(Date:10/15/2014)... increased resistance to bacterial pneumonia in female mice to ... , Females are naturally more resistant to respiratory infections ... shown that increased resistance to bacterial pneumonia in female ... 3 (NOS3). They also show that this enzyme is ... hormone estrogen. , The team, lead by Professor Lester ...
(Date:10/14/2014)... thieves, prostate cancer tumors scavenge and hoard copper that ... avarice may be a fatal weakness. , Researchers ... prostate cancer cells by delivering a trove of copper ... cells brimming with the mineral, leaving non-cancer cells healthy. ... commercially available for other uses, could soon be tested ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Prostate cancer's penchant for copper may be a fatal flaw 2
... have devised a means of identifying partial, distorted, scratched, ... seconds. Previous techniques have tried to identify a ... match them against a database of templates. The University ... each print and transform the topological pattern into a ...
... issue of G&D, Dr. Guillermo Oliver (St. ... evidence to resolve a century-old debate over the ... development of the lymphatic vasculature is integral to ... and maintaining tissue fluid levels) and disease (lymphedema ...
... Acid rain was one of the worlds worst pollution problems ... Britain, as well as Europe and North America. In ... been acidified, harming fish, stream insects and river birds such ... has been taken across Europe to clean up acid pollutants ...
Cached Biology News:New technology identifies warped fingerprints at warp speed 2Recovery from acid rain 'much slower than expected' 2
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected....
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
...
...
Biology Products: